Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.
Adolescent
Adult
Aged
Cross-Sectional Studies
Health Care Surveys
Humans
Inflammatory Bowel Diseases
/ diagnosis
Middle Aged
Office Visits
/ trends
Practice Patterns, Physicians'
/ trends
Preventive Health Services
/ trends
Referral and Consultation
/ trends
Time Factors
United States
/ epidemiology
Young Adult
Crohn’s disease
Inflammatory bowel disease
Preventive care services
Ulcerative colitis
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
04
12
2018
accepted:
24
01
2019
pubmed:
13
2
2019
medline:
24
12
2019
entrez:
13
2
2019
Statut:
ppublish
Résumé
Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care. The population-based study compared the receipt of these services by US adults with and without IBD. Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of doctor visits, receipt of medical advice, and selected preventive care was calculated for adults with and without IBD. The model-adjusted prevalence ratios were estimated for receipt of preventive care associated with IBD. The prevalence of a doctor visit in the past 12 months was significantly higher among adults with IBD than those without. IBD was also associated with significantly higher prevalence of receiving medical advice about smoking cessation (83.9% vs. 66.4%) and diet (42.9% vs. 32.1%), having colon cancer screening in the past 12 months (44.0% vs. 26.7%), having ever had an HIV test (51.5% vs. 45.4%) or pneumococcal vaccine (75.3% vs. 64.0%), having received a tetanus vaccine in the past 10 years (72.0% vs. 61.8%), and having received a flu vaccine in the past 12 months (48.4% vs. 41.0%), but was not significantly associated with receiving cervical cancer screening and hepatitis A and B vaccines. Adults with IBD were more likely to receive many types of preventive care than adults without IBD. The findings can inform healthcare policy makers to make strategic decisions that enhance multidisciplinary coordination from various medical specialties to ensure optimal preventive care for IBD patients.
Sections du résumé
BACKGROUND
Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care.
AIMS
The population-based study compared the receipt of these services by US adults with and without IBD.
METHODS
Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of doctor visits, receipt of medical advice, and selected preventive care was calculated for adults with and without IBD. The model-adjusted prevalence ratios were estimated for receipt of preventive care associated with IBD.
RESULTS
The prevalence of a doctor visit in the past 12 months was significantly higher among adults with IBD than those without. IBD was also associated with significantly higher prevalence of receiving medical advice about smoking cessation (83.9% vs. 66.4%) and diet (42.9% vs. 32.1%), having colon cancer screening in the past 12 months (44.0% vs. 26.7%), having ever had an HIV test (51.5% vs. 45.4%) or pneumococcal vaccine (75.3% vs. 64.0%), having received a tetanus vaccine in the past 10 years (72.0% vs. 61.8%), and having received a flu vaccine in the past 12 months (48.4% vs. 41.0%), but was not significantly associated with receiving cervical cancer screening and hepatitis A and B vaccines.
CONCLUSIONS
Adults with IBD were more likely to receive many types of preventive care than adults without IBD. The findings can inform healthcare policy makers to make strategic decisions that enhance multidisciplinary coordination from various medical specialties to ensure optimal preventive care for IBD patients.
Identifiants
pubmed: 30746631
doi: 10.1007/s10620-019-05494-w
pii: 10.1007/s10620-019-05494-w
pmc: PMC10477928
mid: NIHMS1885864
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1798-1808Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Références
Xu F, Dahlhamer JM, Zammitti EP, Wheaton AG, Croft JB. Health-risk behaviors and chronic conditions among adults with inflammatory bowel disease—United States, 2015 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:190–195. https://doi.org/10.15585/mmwr.mm6706a4 .
doi: 10.15585/mmwr.mm6706a4
pubmed: 29447146
pmcid: 5815485
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s Colitis. 2007;1:10–20. https://doi.org/10.1016/j.crohns.2007.06.005 .
doi: 10.1016/j.crohns.2007.06.005
Roman AL, Munoz F. Comorbidity in inflammatory bowel disease. World J Gastroenterol. 2011;17:2723–2731. https://doi.org/10.3748/wjg.v17.i22.2723 .
doi: 10.3748/wjg.v17.i22.2723
pubmed: 21734780
pmcid: 3122260
Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47–52.
doi: 10.1097/01.MIB.0000191670.04605.e7
pubmed: 16374258
Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Reps. 2008;10:597–605.
doi: 10.1007/s11894-008-0108-6
Murthy SK, Nguyen GC. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011;106:713–718.
doi: 10.1038/ajg.2011.53
pubmed: 21407182
Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons. World J Gastroenterol. 2015;21:9688–9692. https://doi.org/10.3748/wjg.v21.i33.9688 .
doi: 10.3748/wjg.v21.i33.9688
pubmed: 26361415
pmcid: 4562952
Chang M, Chang L, Chang HM, Chang F. Intestinal and extraintestinal cancers associated with inflammatory bowel disease. Clin Colorectal Cancer. 2018;17:e29–e37. https://doi.org/10.1016/j.clcc.2017.06.009 .
doi: 10.1016/j.clcc.2017.06.009
pubmed: 28712945
Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn Colitis. 2014;8:443–468. https://doi.org/10.1016/j.crohns.2013.12.013 .
doi: 10.1016/j.crohns.2013.12.013
Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol. 2016;22:7625–7644. https://doi.org/10.3748/wjg.v22.i34.7625 .
doi: 10.3748/wjg.v22.i34.7625
pubmed: 27678347
pmcid: 5016364
Kremers HM, Bidaut-Russell M, Scott CG, Reinalda MS, Zinsmeister AR, Gabriel SE. Preventive medical services among patients with rheumatoid arthritis. J Rheumatol. 2003;30:1940–1947.
pubmed: 12966594
Owens MD, Beckles GL, Ho KK, Gorrell P, Brady J, Kaftarian JS. Women with diagnosed diabetes across the life stages: underuse of recommended preventive care services. J Women Health (Larchmt). 2008;17:1415–1423. https://doi.org/10.1016/10.1089/jwh.2008.1125 .
doi: 10.1089/jwh.2008.1125
Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Ggastroenterol. 2017;112:241–258. https://doi.org/10.1038/ajg.2016.537 .
doi: 10.1038/ajg.2016.537
Selby L, Hoellein A, Wilson JF. Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci. 2011;56:819–824. https://doi.org/10.1007/s10620-010-1329-8 .
doi: 10.1007/s10620-010-1329-8
pubmed: 20668942
National Center for Health Statistics. Survey Description, National Health Interview Survey. 2015. Hyattsville, Maryland. 2016. Avaiable at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2015/srvydesc.pdf . Accessed July 13, 2018.
National Center for Health Statistics. Survey Description, National Health Interview Survey. 2016. Hyattsville, Maryland. 2017. Avaiable at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2016/srvydesc.pdf . Accessed July 13, 2018.
U.S. Preventive Service Task Force. U.S. Preventive Service Task Force published recommendations. 2017. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index . Accessed February 27, 2018.
Bieler GS, Brown GG, Williams RL, Brogan DJ. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171:618–623. https://doi.org/10.1093/aje/kwp440 .
doi: 10.1093/aje/kwp440
pubmed: 20133516
National Center for Health Statistics. National Center for Health Statistics data presentation standards for proportions. 2017; Available from https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf . Accessed Feburary 23, 2018.
Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14:253–258. https://doi.org/10.1002/ibd.20266 .
doi: 10.1002/ibd.20266
pubmed: 17932966
Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:62–68. https://doi.org/10.1002/ibd.21371 .
doi: 10.1002/ibd.21371
pubmed: 20564532
pmcid: 2962765
Mady R, Grover W, Butrus S. Ocular complications of inflammatory bowel disease. ScientificWorldJournal. 2015;2015:438402. https://doi.org/10.1155/2015/438402 .
doi: 10.1155/2015/438402
pubmed: 25879056
pmcid: 4386693
Severs M, Mangen MJ, van der Valk ME, et al. Smoking is associated with higher disease-related costs and lower health-related quality of life in inflammatory bowel disease. J Crohn’s Colitis. 2017;11:342–352. https://doi.org/10.1093/ecco-jcc/jjw160 .
doi: 10.1093/ecco-jcc/jjw160
Crohn’s & Colitis Foundation. Nutrition, diet, and inflammatory bowel disease. 2013; Available from: http://www.crohnscolitisfoundation.org/resources/diet-nutrition-ibd-2013.pdf . Accessed October 25, 2018.
Halmos EP, Gibson PR. Dietary management of IBD–insights and advice. Nat Rev. Gastroenterol Hepatol. 2015;12:133–146. https://doi.org/10.1038/nrgastro.2015.11 .
doi: 10.1038/nrgastro.2015.11
pubmed: 25645969
Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22:4794–4801. https://doi.org/10.3748/wjg.v22.i20.4794 .
doi: 10.3748/wjg.v22.i20.4794
pubmed: 27239106
pmcid: 4873872
Waszczuk E, Waszczuk K, Bohdanowicz-Pawlak A, Florjanski J. Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine. Gynecol endocrinol. 2018;34:656–658. https://doi.org/10.1080/09513590.2017.1416466 .
doi: 10.1080/09513590.2017.1416466
pubmed: 29475388
Centers for Disease Control and Prevention. The Advisory Committee on Immunization Practices. 2018; Avaiable at: https://www.cdc.gov/vaccines/acip/index.html . Accessed July 16, 2018.
Gurvits GE, Lan G, Tan A, Weissman A. Vaccination practices in patients with inflammatory bowel disease among general internal medicine physicians in the USA. Postgrad Med J. 2017;93:333–337. https://doi.org/10.1136/postgradmedj-2016-134266 .
doi: 10.1136/postgradmedj-2016-134266
pubmed: 27733673
Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014;20:246–250. https://doi.org/10.1097/01.mib.0000437737.68841.87 .
doi: 10.1097/01.MIB.0000437737.68841.87
pubmed: 24374881
pmcid: 4393851
Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohn’s Colitis. 2015;9:439–444. https://doi.org/10.1093/ecco-jcc/jjv064 .
doi: 10.1093/ecco-jcc/jjv064